Cormica Acquires Zwisler Laboratorium GmbH
January 21, 2024
Cormica, a Limerston Capital‑backed life sciences testing group, has acquired Zwisler Laboratorium, a Reichenau, Germany–based laboratory specialising in microbiological and in‑vitro testing. The deal gives Cormica its first foothold in Germany and expands its capabilities for pharmaceutical, biotech, medical device and packaging customers across Europe.
- Buyers
- Cormica, Limerston Capital
- Targets
- Zwisler Laboratorium GmbH
- Sellers
- Dr Zwisler (former owner)
- Platforms
- Cormica
- Industry
- Healthcare Services
- Location
- Baden-Württemberg, Germany
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
Cormica Acquires TPM Laboratories (Cherry Hill, NJ)
May 2, 2024
Healthcare Services
UK-based Cormica, backed by Limerston Capital, has acquired TPM Laboratories, an independent contract testing laboratory in Cherry Hill, New Jersey. The seven-figure, add-on purchase expands Cormica's analytical testing capabilities and establishes its first US presence while TPM's founder, Rupa Iyer, will continue to lead the US operation.
-
Canopy Biosciences Acquires Zellkraftwerk GmbH
April 29, 2019
Biotechnology
Canopy Biosciences acquired Leipzig-based Zellkraftwerk GmbH, adding Zellkraftwerk’s ChipCytometry multiplex cytometry instruments and related services to Canopy’s multi-omics portfolio. Concurrently, Ampersand Capital Partners made a strategic growth investment in Canopy to support geographic expansion and product/service scale-up across the US, Europe and Asia.
-
Calibre Scientific Acquires LINARIS Biologische Produkte GmbH
June 14, 2021
Healthcare Services
Calibre Scientific has acquired LINARIS Biologische Produkte GmbH, a Germany-based life-science distributor, and will integrate it with BIOZOL Diagnostica GmbH to expand product offerings and sales reach in the DACH region. The deal brings LINARIS’s supplier relationships and technical expertise into Calibre’s BIOZOL platform to strengthen its position in the German research and diagnostics market.
-
Verdesian Life Sciences Acquires Cytozyme Laboratories
April 27, 2021
Agriculture
Verdesian Life Sciences has acquired Cytozyme Laboratories, Inc.; Cascadia Capital served as exclusive financial advisor to Cytozyme. The acquisition brings together complementary biological and nutritional crop technologies to expand Verdesian's product portfolio and support sustainable yield solutions for growers.
-
Sverica Capital Management Makes Growth Investment in Zyston
July 11, 2023
Cybersecurity
Sverica Capital Management has made a strategic growth investment in Zyston, a provider of managed detection and response and AI-driven cybersecurity program management software. Zyston's founder and CEO Craig Stamm will remain in place and Sverica partners Frank Young and Michael Dougherty will join Zyston's board to support the company's continued growth and expansion of services.
-
Keystone Capital Forms Gillson Sciences via Acquisition of Azzur Labs and Micro Measurement Laboratories
August 6, 2025
Healthcare Services
Keystone Capital Management has formed Gillson Sciences, a laboratory testing, monitoring and advisory platform focused on pharmaceuticals, biopharma, medical devices, healthcare and environmental sciences, by acquiring Azzur Labs (now Gillson Testing) and Micro Measurement Laboratories. Jason Fischer has been named CEO to lead the build-up strategy; terms were not disclosed.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.